MX2015000348A - Metodos para preparar triazolopiridinas sustituidas. - Google Patents

Metodos para preparar triazolopiridinas sustituidas.

Info

Publication number
MX2015000348A
MX2015000348A MX2015000348A MX2015000348A MX2015000348A MX 2015000348 A MX2015000348 A MX 2015000348A MX 2015000348 A MX2015000348 A MX 2015000348A MX 2015000348 A MX2015000348 A MX 2015000348A MX 2015000348 A MX2015000348 A MX 2015000348A
Authority
MX
Mexico
Prior art keywords
preparing substituted
substituted triazolopyridines
compounds
triazolopyridines
preparing
Prior art date
Application number
MX2015000348A
Other languages
English (en)
Spanish (es)
Inventor
Volker Schulze
Franz-Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of MX2015000348A publication Critical patent/MX2015000348A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2015000348A 2012-07-10 2013-07-03 Metodos para preparar triazolopiridinas sustituidas. MX2015000348A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
MX2015000348A true MX2015000348A (es) 2015-04-14

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000348A MX2015000348A (es) 2012-07-10 2013-07-03 Metodos para preparar triazolopiridinas sustituidas.

Country Status (24)

Country Link
US (1) US9388177B2 (enExample)
EP (1) EP2872506A1 (enExample)
JP (1) JP6238979B2 (enExample)
KR (1) KR20150040845A (enExample)
CN (1) CN104603136B (enExample)
AP (1) AP3778A (enExample)
AU (1) AU2013289381A1 (enExample)
BR (1) BR112015000308A2 (enExample)
CA (1) CA2878481A1 (enExample)
CL (1) CL2015000038A1 (enExample)
CO (1) CO7160002A2 (enExample)
CR (1) CR20150006A (enExample)
DO (1) DOP2015000007A (enExample)
EA (1) EA027544B1 (enExample)
HK (1) HK1206731A1 (enExample)
IL (1) IL236265A (enExample)
IN (1) IN2015DN00085A (enExample)
MX (1) MX2015000348A (enExample)
NZ (1) NZ703020A (enExample)
PE (1) PE20150354A1 (enExample)
PH (1) PH12015500061A1 (enExample)
SG (1) SG11201408419QA (enExample)
TN (1) TN2015000008A1 (enExample)
WO (1) WO2014009219A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195276A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
DK3008062T3 (en) * 2013-06-11 2017-06-12 Bayer Pharma AG PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES
US20160128988A1 (en) 2013-06-11 2016-05-12 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
US11208696B2 (en) 2015-04-17 2021-12-28 Netherlands Translational Research Center B.V. Prognostic biomarkers for TTK inhibitor chemotherapy
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009812A1 (en) * 2001-10-05 2005-01-13 Takuya Seko Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
CA2566158A1 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
JP2008515874A (ja) * 2004-10-07 2008-05-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌薬
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
US7557104B2 (en) * 2006-06-06 2009-07-07 Schering Corporation Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
MX2009002171A (es) 2006-08-30 2009-05-28 Cellzome Ltd Derivados de triazol como inhibidores de cinasas.
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
AU2008277628B2 (en) 2007-07-18 2012-03-15 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
CN103298814A (zh) 2007-08-23 2013-09-11 阿斯利康(瑞典)有限公司 作为治疗增殖性疾病的ttk/mps1抑制剂的2-苯胺基嘌呤-8-酮
KR20100075881A (ko) 2007-08-31 2010-07-05 메르크 세로노 에스. 에이. 트리아졸로피리딘 화합물 및 ａｓｋ 저해제로서 이의 용도
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
EP2303890A4 (en) * 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
CA2751517A1 (en) 2009-02-13 2010-08-19 Fovea Pharmaceuticals [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
EP2424537B1 (en) 2009-04-29 2015-07-08 Bayer Intellectual Property GmbH Substituted imidazoquinoxalines
CA2763900A1 (en) * 2009-06-05 2010-12-09 Cephalon, Inc. Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
EP2473498A1 (en) 2009-09-04 2012-07-11 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343295A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
AU2012244859B2 (en) * 2011-04-21 2017-06-08 Bayer Intellectual Property Gmbh Triazolopyridines
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
US9388177B2 (en) 2016-07-12
PE20150354A1 (es) 2015-03-21
KR20150040845A (ko) 2015-04-15
CO7160002A2 (es) 2015-01-15
US20150148542A1 (en) 2015-05-28
PH12015500061A1 (en) 2015-03-02
BR112015000308A2 (pt) 2017-06-27
AU2013289381A1 (en) 2015-01-22
JP2015523372A (ja) 2015-08-13
SG11201408419QA (en) 2015-01-29
AP2014008177A0 (en) 2014-12-31
CA2878481A1 (en) 2014-01-16
CR20150006A (es) 2015-02-16
IL236265A0 (en) 2015-02-26
NZ703020A (en) 2017-08-25
CL2015000038A1 (es) 2015-03-13
IN2015DN00085A (enExample) 2015-05-29
IL236265A (en) 2017-07-31
CN104603136B (zh) 2017-06-27
CN104603136A (zh) 2015-05-06
TN2015000008A1 (en) 2016-06-29
WO2014009219A1 (en) 2014-01-16
HK1206731A1 (en) 2016-01-15
EA201590116A1 (ru) 2015-07-30
EP2872506A1 (en) 2015-05-20
AP3778A (en) 2016-08-31
EA027544B1 (ru) 2017-08-31
JP6238979B2 (ja) 2017-11-29
DOP2015000007A (es) 2015-02-15

Similar Documents

Publication Publication Date Title
AU2012213775A8 (en) 7-azaindole derivatives
MD20150091A2 (ro) Compuşi antivirali
UA111186C2 (uk) Способи та композиції для одержання норибогаїну з воакангіну
MY167697A (en) Method for producing 4,4-difluoro-3,4- dihydroisoquinoline derivatives
MX2015005944A (es) Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas.
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
PH12014501258A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
EA201590887A1 (ru) Композиция
PH12013502169A1 (en) Triazolopyridines
IN2015KN00323A (enExample)
GEP201706690B (en) Novel process for making compounds for use in treatment of cancer
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GEP201706626B (en) Synthesis of (s)-nifuratel
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
GB201107985D0 (en) Process
IN2014DN09451A (enExample)
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
MX367773B (es) Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos.
WO2013072938A3 (en) Process for the preparation of roflumilast
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
IN2014DN10135A (enExample)
IN2014DN07407A (enExample)
IN2015DN02513A (enExample)
PH12015502703A1 (en) Pharmaceutical compositions
IN2013MU01219A (enExample)